| 
				1 | 
			
			OBBB Act to impact Indian pharma cos in Medicaid cuts, PBM reforms, orphan drug exemptions: Experts			 | 
			
				News Articles
			 | 
		
				
			| 
				2 | 
			
			US FDA grants orphan drug & rare paediatric disease designations to Cumberland Pharma’s Ifetroban to treat cardiomyopathy associated with DMD			 | 
			
				News Articles
			 | 
		
				
			| 
				3 | 
			
			Awareness Seminar on Rare Diseases/Orphan Drugs			 | 
			
				Member Circulars
			 | 
		
				
			| 
				4 | 
			
			Important Technical Seminars on Quality Compliance & Orphan Drugs			 | 
			
				Member Circulars
			 | 
		
				
			| 
				5 | 
			
			Two Day Technical Seminars: Quality Culture in GMP Compliance, Drugs for Rare Diseases (Orphan Drugs) - Govt. Initiatives & Opportunities			 | 
			
				Member Circulars
			 | 
		
				
			| 
				6 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA on 25th September 2013, Hyderabad			 | 
			
				Member Circulars
			 | 
		
				
			| 
				7 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				8 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				9 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				10 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				11 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				12 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				13 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				14 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				15 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				16 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				17 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				18 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				19 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				20 | 
			
			One Day Seminar on Overseas Marketing Strategies, Opportunities for Orphan Drugs, IPR & Interaction with Kenyan FDA			 | 
			
				Conference and Presentations
			 | 
		
				
			| 
				
		  |